Research Posters

Characteristics of Drug Checking Programs in 2022: Findings from the North American Drug Checking Survey

Stakeholders’ perspectives on the role of stigma in authorizing and implementing safe consumption sites in the United States: a qualitative study

Stakeholders’ perspectives on the role of stigma in authorizing and implementing safe consumption sites in the United States: a qualitative study

Stakeholders’ perspectives on the role of stigma in authorizing and implementing safe consumption sites in the United States: a qualitative study

Stakeholders’ perspectives on the role of stigma in authorizing and implementing safe consumption sites in the United States: a qualitative study

Stakeholders’ perspectives on the role of stigma in authorizing and implementing safe consumption sites in the United States: a qualitative study

Validation of Rapid Fentanyl and Xylazine Test Strips and FT-IR Spectroscopy for Use in Community Based Settings

Stakeholders’ perspectives on the role of stigma in authorizing and implementing safe consumption sites in the United States: a qualitative study

Enabling and constraining forces on the operation and implementation of drug checking programs in Latin America: a qualitative study

Enabling and constraining forces on the operation and implementation of drug checking programs in Latin America: a qualitative study

Sleep Disruption in Patients Receiving Medications for Opioid Use Disorder (OUD) is Associated with Socioeconomic Intersectionality and Psychologic Comorbidity

Enabling and constraining forces on the operation and implementation of drug checking programs in Latin America: a qualitative study

Overdose Detection Technologies for People Who Use Alone

Sleep Disruption in Patients Receiving Medications for Opioid Use Disorder (OUD) is Associated with Socioeconomic Intersectionality and Psychologic Comorbidity

Sleep Disruption in Patients Receiving Medications for Opioid Use Disorder (OUD) is Associated with Socioeconomic Intersectionality and Psychologic Comorbidity

Sleep Disruption in Patients Receiving Medications for Opioid Use Disorder (OUD) is Associated with Socioeconomic Intersectionality and Psychologic Comorbidity

Sleep Disruption in Patients Receiving Medications for Opioid Use Disorder (OUD) is Associated with Socioeconomic Intersectionality and Psychologic Comorbidity

Sleep Disruption in Patients Receiving Medications for Opioid Use Disorder (OUD) is Associated with Socioeconomic Intersectionality and Psychologic Comorbidity